Pharmaceutical Industry Articles & Reports - Page 10

Understand Computer System Validation (CSV) in pharma. This guide explains GAMP 5 Second Edition implementation, 21 CFR Part 11, and data integrity. Read more.

Analyze enterprise AI admin dashboards and usage controls for ChatGPT and Claude. This guide covers security, compliance, RBAC, and analytics features.

Examine the systemic causes of enterprise AI rollout failures. This report analyzes how poor data readiness, flawed integration, and overhype impact AI ROI.

An analysis of EU AI Act high-risk compliance for pharmaceutical and medical device AI. Covers MDR/IVDR integration, data governance, and 2026 deadlines.

Analyze GLP-1 drug manufacturing dynamics, detailing global capacity expansions, CDMO production strategies, and peptide synthesis tech transfer processes.

Examine HCP Master Data Management in pharma. Review data validation rules, identity verification, and Sunshine Act compliance for aggregate spend reporting.

Review the key changes in IEC 62304 Edition 2 for medical device software. This 2026 guide covers revised safety levels, AI/ML compliance, and expanded scope.

An in-depth comparative analysis of Peer AI and Weave Bio. Examine how these regulatory AI tools utilize LLMs to automate biopharma submission documents.

Examine frameworks for calculating AI ROI in the pharmaceutical sector. Analyze quantitative metrics and payback periods for PV, regulatory, and manufacturing.

Understand the architecture of GxP-compliant data pipelines for pharma AI. This report analyzes data engineering frameworks using Databricks and Snowflake.

Analyze CRO data integration patterns in clinical trials. Learn how sponsors use clinical data lakehouses, APIs, and AI for real-time data independence.

Examine how LLMs like ChatGPT fail in pharma and biotech. Review documented cases of fabricated clinical trials, wrong MOA descriptions, and fake citations.

An analysis of Moderna's enterprise AI adoption strategy. Learn how the company achieved 100% generative AI usage through OpenAI tools and change management.

Analyze the shift from prompt engineering to context engineering in AI. Learn how curating knowledge, memory, and data improves enterprise LLM reliability.

Analyze Dotmatics' evolving natural language query capabilities, AI integration via the Luma platform, and the technical mechanisms of scientific LLM search.

Examine the January 2025 FDA draft guidance on AI in drug development. This report details the 7-step credibility framework and excluded AI applications.

Explore the technical architecture of the Egnyte MCP Server. This guide explains how Model Context Protocol securely connects enterprise data with AI tools.

Examine the enterprise AI knowledge stack. Learn how RAG architecture and tools like Egnyte Copilot turn file repositories into source-grounded AI systems.

Learn how pharma companies transition to AI operating models. Compare Moderna's workforce education, Sanofi's enterprise integration, and BMS's predictive R&D.

Examine how generative AI is transitioning from experimental tools to core AI-native workflow software in legal, regulatory, and clinical research operations.

Examine why enterprise AI demands custom infrastructure, compute, and data pipelines over generic chat apps, featuring the Eli Lilly supercomputer case study.

Explore shadow AI in biotech and life sciences. This report details unsanctioned generative AI usage, data privacy risks, and enterprise governance strategies.

Examine why AI literature review leads biotech R&D with 76% adoption. This report analyzes NLP tools, knowledge extraction, efficiency gains, and future trends.

Compare AI research assistants for drug discovery. Examine how Causaly, Elicit, Consensus, and Semantic Scholar synthesize biomedical literature for R&D.